Kyinno

Yunnan Baiyao Group Co., Ltd (SHE: 000538), a traditional Chinese medicine (TCM) company based in Kunming, has entered into a licensing agreement with Chinese firm Kyinno Biotechnology. Through this agreement, Yunnan Baiyao secures the global research and development (R&D), manufacturing, and commercialization rights for Kyinno’s antibody drug, KA-1641. The agreement…